Company / Accounts Receivable
Doximity Accounts Receivable History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$128.4M
FY2025
5-year range
$50.3M / $128.4M
FY2021-FY2025
Trend
+26.7%
vs FY2024
Sector context
#89 of 143
Health Care
What the data says
At $128M, Doximity's accounts receivable ranks #89 of 143 in the Health Care sector. Improved from $107M to $128M over the past 2 years.
Based on SEC 10-K filings.
$128M in FY2025 with a 3-year CAGR of +16.5%.
Improved from $107M to $128M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +16.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#89 of 143 in Health CareTop 62% of 143This company $128.4M Sector average $1.3B
▼
-90.3% below sector average
Key checks
Key Insights
- 3-year CAGR of +16.5%, indicating consistent growth.
- In FY2025, accounts receivable increased 26.7% year-over-year.
- Ranks #89 out of 143 companies in the Health Care sector.
- Lowest accounts receivable in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $128.4M | +26.7% |
| FY2024 | $101.3M | -5.3% |
| FY2023 | $107.0M | +32.0% |
| FY2022 | $81.1M | +61.1% |
| FY2021 | $50.3M | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026